Clinical Trial Update: Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating F18-choline as a second-line tracer for detecting parathyroid adenomas in hyperparathyroidism, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• F18-choline

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Hyperparathyroidism | Phase 2 | Status: COMPLETED